Telesis Bio Inc (NASDAQ: TBIO) has experienced a decline in its stock price by -9.97 compared to its previous closing price of 0.34. However, the company has seen a fall of -15.24% in its stock price over the last five trading days. InvestorPlace reported 2024-02-23 that Telesis Bio (NASDAQ: TBIO ) stock is on the rise Friday as the synthetic biology company’s shares experienced heavy trading this morning. Shares of TBIO stock are off to a strong start on Friday with some 7.4 million shares changing hands as of this writing.
Is It Worth Investing in Telesis Bio Inc (NASDAQ: TBIO) Right Now?
Additionally, the 36-month beta value for TBIO is 1.93. There are mixed opinions on the stock, with 1 analysts rating it as a “buy,” 1 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for TBIO is 8.68M and currently, short sellers hold a 1.21% ratio of that float. The average trading volume of TBIO on May 08, 2024 was 765.80K shares.
TBIO’s Market Performance
TBIO stock saw a decrease of -15.24% in the past week, with a monthly decline of -28.95% and a quarterly a decrease of -6.11%. The volatility ratio for the week is 12.33%, and the volatility levels for the last 30 days are 12.93% for Telesis Bio Inc (TBIO). The simple moving average for the past 20 days is -14.38% for TBIO’s stock, with a -55.89% simple moving average for the past 200 days.
TBIO Trading at -30.88% from the 50-Day Moving Average
After a stumble in the market that brought TBIO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -89.83% of loss for the given period.
Volatility was left at 12.93%, however, over the last 30 days, the volatility rate increased by 12.33%, as shares sank -28.85% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -53.64% lower at present.
During the last 5 trading sessions, TBIO fell by -15.24%, which changed the moving average for the period of 200-days by -77.33% in comparison to the 20-day moving average, which settled at $0.3512. In addition, Telesis Bio Inc saw -23.31% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for TBIO
Current profitability levels for the company are sitting at:
- -1.28 for the present operating margin
- 0.59 for the gross margin
The net margin for Telesis Bio Inc stands at -1.73. The total capital return value is set at -0.56. Equity return is now at value -125.42, with -62.89 for asset returns.
Based on Telesis Bio Inc (TBIO), the company’s capital structure generated 0.19 points at debt to capital in total, while cash flow to debt ratio is standing at -4.89. The debt to equity ratio resting at 0.24. The interest coverage ratio of the stock is -11.32.
Currently, EBITDA for the company is -31.05 million with net debt to EBITDA at -0.98. When we switch over and look at the enterprise to sales, we see a ratio of 1.52. The receivables turnover for the company is 4.6for trailing twelve months and the total asset turnover is 0.39. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.71.
Conclusion
In conclusion, Telesis Bio Inc (TBIO) has seen bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
